iBio, Inc.
IBIO
$1.26
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -- | -- | 14.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -- | -- | 14.29% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -- | -- | -- | 14.29% |
| SG&A Expenses | -200.37% | 71.91% | 88.37% | -10.71% | -11.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.14% | 71.45% | 104.48% | 47.37% | 50.61% |
| Operating Income | -22.68% | -71.45% | -113.74% | -44.93% | -52.48% |
| Income Before Tax | -105.33% | -59.02% | -106.07% | -43.39% | -59.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -105.33% | -59.02% | -106.07% | -43.39% | -59.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.33% | -59.02% | -106.07% | -43.39% | 33.62% |
| EBIT | -22.68% | -71.45% | -113.74% | -44.93% | -52.48% |
| EBITDA | -24.40% | -75.27% | -120.15% | -47.07% | -56.87% |
| EPS Basic | 79.68% | 86.89% | 81.02% | 37.05% | 60.41% |
| Normalized Basic EPS | 89.25% | 86.89% | 81.02% | 37.05% | 5.16% |
| EPS Diluted | 79.68% | 86.89% | 81.02% | 37.05% | 60.41% |
| Normalized Diluted EPS | 89.25% | 86.89% | 81.02% | 37.05% | 5.16% |
| Average Basic Shares Outstanding | 910.11% | 1,112.74% | 985.56% | 127.80% | 67.66% |
| Average Diluted Shares Outstanding | 910.11% | 1,112.74% | 985.56% | 127.80% | 67.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |